Krakatoa Jardim Becomes the First Official Distributor of SYNLawn in Portugal
12.12.2024 05:00:00 CET | ACCESS Newswire | Press release
AVEIRO, PT / ACCESSWIRE / December 12, 2024 / Krakatoa Jardim, a garden construction and maintenance business, announced it has joined the global network of distributors of SYNLawn, an international manufacturer and innovator of bio-based artificial grass. As an official and exclusive distributor of SYNLawn in Portugal, the company will carry SYNLawn's premium line of synthetic turf and surfacing products.
"We're excited to be the first distributor of SYNLawn in Portugal," said António Matos, the owner and CEO of Krakatoa Jardim. "We look forward to offering SYNLawn's innovative products to our commercial and residential clients to enhance their landscaping projects."
Krakatoa Jardim started its business more than 20 years ago. In addition to offering garden construction and maintenance services, the company imports outdoor furniture directly from Bali, Indonesia, which it incorporates into its landscaping designs. In the past decade, the company started installing artificial turf. The company team includes Rita Raposo, a landscape architect, and 10 gardeners.
"We're very pleased to offer our plant-based artificial grass products to the people of Portugal," said George Neagle, president of SYNLawn Global. "Improving environmental sustainability in the landscaping industry is a primary initiative of our company. We are delighted to help Krakatoa Jardim provide their clients with more sustainable landscaping solutions."
"We are delighted to welcome Krakatoa Jardim as our first partner in Portugal," said Wolfgang Beck, Business Unit Manager of SYNLawn Europe. "In addition to our shared vision of offering premium products to the Portuguese market, we have been on the same wavelength from the very first moment, not only in business but also as people. This will be the beginning of a long, successful partnership."
Krakatoa Jardim is located at Avenida Europa 257 Cacia 3800-533 in Aveiro. Visit www.krakatoajardim.com for more information about the expert services and products offered by the company. Contact Krakatoa Jardim by phone at +351 234 186 525. Learn more about SYNLawn and its premium line of artificial turf products at SYNLawn.com.
About SYNLawn®
For more than 20 years, SYNLawn® has led the industry as the largest manufacturer and unrivaled innovator of artificial grass and synthetic surfacing. As part of the Sport Group Holding® family of companies, SYNLawn delivers the best products available on the market. SYNLawn's product offerings also include Calico Greens™, an upscale line of artificial wall displays. SYNLawn's turnkey network of over 120 distributors seamlessly combines environmental stewardship with industry-leading innovations. SYNLawn uses PCR content and bio-based ingredients and consumer-conscious additives to meet customers' wide range of needs. With more than 350,000 residential and commercial installations, the company is raising the bar for global synthetic turf standards and transforming the idea of grass. SYNLawn has installed over 150 million square feet of U.S. soy-backed grass in the United States of America and over 30 other countries since 2008. SYNLawn added more soy than ever to its products in 2021. For more information, visit www.SYNLawn.com and follow on Facebook, Instagram, LinkedIn, Pinterest and YouTube.
Contact Information
Mackenzie Smith
mackenzie@labearcommunications.com
574-524-5916
SOURCE: SYNLawn
View the original press release on accesswire.com
SYNLawn
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom